Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023 at 06:02 AM EDT
Donanemab, a monthly antibody infusion made by pharmaceutical company Eli Lilly, also significantly reduced brain plaque associated with Alzheimer's disease.
